Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 40
Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 121
Humana Adds Physicians in Florida
Humana (NYSE: HUM) hasn’t made a lot of waves in the Physician Medical Group sector. Its larger managed care rival, UnitedHealth Group’s Optum (NYSE: UNH), spent approximately $8.2 billion on two large physician practice acquisitions in 2017 alone. There’s also the distraction of acquisition talks with one of the world’s largest retailers, Walmart (NYSE: WMT), which were revealed by The Wall Street Journal in April 2018. While those talks are ongoing, Humana is honing its Medicare and Medicare Advantage services with the recent acquisition of Family Physicians Group based in Orlando, Florida. Financial terms were not disclosed, but it’s a safe bet they were... Read More »
CooperSurgical Adds to Its IVF Business
CooperSurgical (NYSE: COO), a subsidiary of The Cooper Companies, Inc., has added another medical device maker focused on women’s health. This is CooperSurgical’s first acquisition in 2018, and it didn’t go far from its Trumbull, Connecticut offices to find The LifeGlobal Group in Guilford, Connecticut. LifeGlobal is a leading provider of in vitro fertilization (IVF) products and devices, with operating facilities in the United States, Canada, Europe, Hong Kong and distributors in some 90 countries worldwide. The acquisition is expected to strengthen CooperSurgical’s fertility media offering and thus improve its industry leading fertility business overall. The deal... Read More »
PE Firms Join to Form Home Health Care Giant
Consolidation isn’t a novel concept in the healthcare market, although it has been slow to arrive for some. The Home Health & Hospice sector has experienced a few jolts in the past six months, as three publicly traded giants merged or were split up. Now the private equity side has sent a shock wave through this sector, pulling together three separate platform companies into a major contender. Blue Wolf Capital Partners, which has backed both Great Lakes Caring and National Home Health Care for the past two years, joined with Kelso & Company to acquire Jordan Health Services from Palladium Equity Partners, LLC. Financial terms were not disclosed. Upon closing the transaction... Read More »
Health Care M&A Weekly Deals, The Week Ending April 6, 2018
We hope you are enjoying your membership to HealthCareMandA.com. This Health Care M&A Weekly chart below is a selection of transactions announced during the prior week(s). The deals presented here are further elaborated in the monthly newsletter, Health Care M&A News, and in the quarterly report. This information also appears in our online database, Deal Search Online. Visit www.dealsearchonline.com to open a guest account and begin your search. Biotechnology Acquirer Target Price Agilent Technologies Inc. Lasergen, Inc. $105 million MedImmune Exclusive license to antibody products $10 million Ferring Pharmaceuticals Rebiotix Inc. N/A UCB S.A. Element Genomics $30 million Novo... Read More »
Imaging Deals Light Up
In the first week of April 2018, five transactions for physician medical practices were announced. That’s a good start to the second quarter, following Q1:18’s deal volume of 35 transactions targeting physicians and their practices. Two of the April deals were for radiology centers. One was announced by RadNet, Inc. (NASDAQ: RDNT), the largest provider of fixed-site outpatient diagnostic imaging services in the United States with 259 centers currently. It just added five more in and around the Fresno, California metropolitan area. The targets include Sierra Imaging Associates (one facility), Women’s Imaging Specialists in Healthcare (three facilities) and Valley Metabolic... Read More »March Added One Mega-Deal, and Saw Another One Halted
After a busy M&A month in February, with 125 deals reported, March didn’t disappoint. Preliminary results show deal volume equaled the previous month’s total. The figures look good, in the face of the recent stock market swings, the Trump administration’s talk of trade wars and cancelling trade deals. But a look back to March 2017 shows this month’s deal volume is down 19% compared with the 155 deals logged then. And that wase in the face of the Trump administration’s efforts to repeal and replace the Affordable Care Act. Check out the April issue of Health Care M&A News for the deal volume and value charts, by sector. We’re not saying this year’s healthcare market is lacking in... Read More »
Digital Health Deals Are Blooming
The eHealth sector is on a roll, and the momentum seems to be gaining every month. Deal volume in the first quarter of 2018, at 45 announced transactions, was 50% higher than in the fourth quarter of 2017. With only four deals fewer than the same quarter in 2017, the 8% dip in deal volume hardly counts as a sell-off. Deal values, which aren’t a solid measure of growth in mergers and acquisitions, were still impressive. In Q1:18, digital health transactions totalled approximately $3.9 billion, up 96% compared with the same quarter a year earlier. That puts the eHealth sector ahead of the Pharmaceuticals sector, which has endured at least 18 months of slow M&A activity. Pharma’s dollar... Read More »
Q1:18 Results: Healthcare Goes Retail
First, the easy news. Deal volume in the first quarter of 2018 was on par with the previous quarter’s total of 380 deals. Preliminary data show 378 transactions were announced in the first quarter, making for a decline of 1% that will likely be erased as more deal activity is uncovered. Compared with the first quarter in 2017, however, deal volume was down 14%, versus the 439 deals reported then. Deal value for the quarter is where the data deviates from previous norms. The first quarter in 2017 posted a very robust $59.6 billion in disclosed deal value. In the fourth quarter of the year, deal value leapt to nearly $115.0 billion, thanks largely to the $77 billion proposed acquisition of... Read More »
Health Care M&A Weekly Deals, The Week Ending March 30, 2018
We hope you are enjoying your membership to HealthCareMandA.com. This Health Care M&A Weekly chart below is a selection of transactions announced during the prior week(s). The deals presented here are further elaborated in the monthly newsletter, Health Care M&A News, and in the quarterly report. This information also appears in our online database, Deal Search Online. Visit www.dealsearchonline.com to open a guest account and begin your search. Biotechnology Acquirer Target Price Celgene Corporation Exclusive worldwide license to ABX-1772 N/A BioIVT Ascendance Biotechnology, Inc. N/A Roivant Sciences Exclusive license to lefamulin $5 million Hospitals Acquirer Target Price IK... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
